Abstract:Yinhui Zeng, 1, &ast Jinyuan Li, 1, &ast Yueqiang Wen, 2, &ast Haiqing Xiao, 1 Chao Yang, 1 Qingxiang Zeng, 1 Wenlong Liu 1 1 Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, 510623, People's Republic of China; 2 Department of Nephrology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510260, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wenlong Liu, Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, 510623, People's Republic of China, Email Purpose: Eosinophils have pivotal roles in the development of allergic rhinitis (AR) through the release of cytotoxic substances. Apolipoprotein A-I (Apo-AI) exhibits a strong inhibitory effect on eosinophil infiltration in allergic diseases. Nevertheless, the precise impact of Apolipoprotein A-I on eosinophils remains uncertain. Methods: Our study recruited a total of 15 AR children and 15 controls. The correlation between Apo-AI expression and the counts of blood eosinophils was examined. Flow cytometry was employed to assess the role of Apo-AI in eosinophil apoptosis and adhesion. The Transwell system was performed to conduct the migration assay. An animal model using AR mice was established to test the effect of Apo-AI on eosinophils. Results: Serum Apo-AI were negatively related to eosinophils counts and eosinophil chemotactic protein levels in AR. Apo-AI exerts a pro-apoptotic effect while also impeding the processes of adhesion, migration, and activation of eosinophils. The apoptosis triggered by Apo-AI was facilitated through the phosphoinositide 3-kinase (PI3K) pathway. The chemotaxis and activation of eosinophils, which are influenced by Apolipoprotein A-I, are regulated through the PI3K and MAPK signaling pathways. Apo-AI treated mice presented with decreased blood and nasal eosinophilic inflammation as well as down-regulated eosinophil related cytokines. Conclusion: Our findings provide confirmation that Apo-AI exhibits inhibitory effects on the function of eosinophils in allergic rhinitis. This suggests that Apo-AI holds potential as a therapeutic target for future treatment strategies. Keywords: apolipoprotein A-I, eosinophils, allergic rhinitis, apoptosis, adhesion, migration, activation Allergic rhinitis (AR) is a worldwide prevalent condition, with a prevalence rate exceeding 10% of the population. 1 Eosinophils are known to have significant involvement in the pathophysiological mechanisms of AR through the secretion of T helper 2 (Th2) cytokines, which in turn produce type 2 inflammation. 2 Besides, various toxic substance can be released by eosinophils, such as major basic proteins, etc. These proteins have the ability to promote tissue damage and amplify allergic inflammation. 3 Eotaxins, secreted by epithelium after Th2 cytokines stimulation, recruit and activate eosinophils. 4 Apolipoprotein A-I (Apo-AI), a prominent constituent of high-density lipoproteins, contributes to pathogenesis of atherosclerosis in coronary heart disease. 5 Moreover, Apo-AI has anti-inflammatory effects by inhibiting dendritic cell maturation, suppress T cell activation, reducing cytokine production by macrophage. 6–8 It is reported that Apo-AI protects the lung by decreasing eosinophil counts in the OVA-sensitized mice after 4F treatments. 9 Genetic removal of Apo-AI can enhance pulmonary inflammation and airway hyperresponsiveness. 10 However, the direct role of Apo-AI in eosinophilic inflammation was not fully understood. The primary aims of our research were to explore the effect of Apo-AI on the function of eosinophils using both in vitro and in vivo experimentation. A total of 15 patients with persistent AR as defined by ARIA criteria and 15 healthy subjects were enrolled from our center. 11 All AR patients fulfilled the following criteria: at least 2 years' disease history, positive skin prick test or specific IgE values to at least one type of common aeroallergens. All healthy subjects have no nasal diseases and positive results to common aeroallergens. All participants included in the study did not have a history of asthma (excluded by spirometric measurements), recent respiratory system infection, or usage of anti-allergic medications, systemic or topical corticosteroids in one month before visits. Peripheral blood -Abstract Truncated-

The Immunosuppressive Functions of Eosinophils Are Compromised in Patients With Allergic Rhinitis, Particularly Concerning Rab27a Expression

Characterization of the immune suppressive functions of eosinophils

IL-27 Signaling Negatively Regulates FcɛRI-mediated Mast Cell Activation and Allergic Response

Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma

CD69 Signaling in Eosinophils Induces IL-10 Production and Apoptosis via the Erk1/2 and JNK Pathways, Respectively

CCR3 gene knockout inhibits proliferation, differentiation, and migration of eosinophils in allergic rhinitis model mice

Exogenous interleukin-17A inhibits eosinophil differentiation and alleviates allergic airway inflammation.

Cd69 Expression on Airway Eosinophils and Airway Inflammation in A Murine Model of Asthma

An eosinophil-Sos1-RAS axis licenses corticosteroid resistance in patients with allergic rhinitis

ADRB2 Suppresses IL-13-induced Allergic Rhinitis Inflammatory Cytokine Regulated by Mir-15A-5p

IgE directly affects eosinophil migration in CRSwNP through CCR3 and predicts the efficacy of omalizumab

[The Significance of Eosinophils in the Correlation of Upper and Lower Airway Inflammation in Patients with Chronic Rhinitis].

Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significance

Rapamycin Inhibition of Eosinophil Differentiation Attenuates Allergic Airway Inflammation in Mice.

MiR-193b-3p Regulates TLR4 Expression to Inhibit Inflammation by Targeting ETS1 in Allergic Rhinitis.

Emerging Role of Eosinophils in Resolution of Arthritis

Mechanism of miR-181a-5p in Regulatory T/T-Helper 17 Immune Imbalance and Asthma Development in Mice with Allergic Rhinitis

Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment

Inhibitory Effect of Apolipoprotein A-I on Eosinophils in Allergic Rhinitis in vitro and in vivo

Type 2 Inflammation Suppression by T-regulatory Cells Attenuates the Eosinophil Recruitment in Mucosa of Chronic Sinusitis.

Endoplasmic Reticulum Stress Promotes Telomerase Reverse Transcriptase Expression Contributes to Development of Allergic Rhinitis